Associated Papers
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival.
Varghese AM et al.
Nature Medicine, 2025
39753968 (PubMed )
Supplement: 41591_2024_3362_MOESM2_ESM.xlsx › SupplementaryTable2_IMPACT_Alts
SWI/SNF chromatin remodeling complex alterations in meningioma.
Gill CM et al.
Journal of Cancer Research and Clinical Oncology, 2021
NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.
Bertucci F et al.
Molecular Oncology, 2020
31854063 (PubMed )
Supplement: MOL2-14-504-s010.xlsx › TableS3
Durable response to olaparib in pancreatic duct adenocarcinoma with deleterious ARID1A mutation.
Zhao XS et al.
Chinese Medical Journal, 2019
Patients with genetically heterogeneous synchronous colorectal cancer carry rare damaging germline mutations in immune-related genes.
Cereda M et al.
Nature Communications, 2016
27377421 (PubMed )
Supplement: ncomms12072-s2.xlsx › UH11T1
Select a paper to view details